Global Bone Morphogenetic Proteins Market 2019 Global Industry Growth Analysis, Segmentation, Size, Share, Trend, Future Demand and Leading Players Updates by Forecast to 2026

The global bone morphogenetic proteins market is likely to gain momentum from a rise in the prevalence of traumatic injuries. Fortune Business Insights, in an upcoming report, titled, “Bone Morphogenetic Proteins Market Size, Share and Global Trend By Type (rhBMP-2, rhBMP-7, Others), By Application (Spinal Fusion, Trauma Surgery, Reconstructive Surgery, Maxillofacial & Dental), and Geography Forecast till 2026,” states that increasing number of spinal fusion procedures and a rise in the investments by prominent market players in the research and development are anticipated to boost the global market growth during the forecast period.

Moreover, bone morphogenetic proteins possess several advantages, such as minimally invasive surgeries, faster recovery, and shorter hospital stays. These are few of the other significant driving factors of the global market.

Browse Full Report:
https://www.fortunebusinessinsights.com/industry-reports/bone-morphogenetic-proteins-market-100346

Fortune Business Insights profiles some of the prominent key players operating in the global bone morphogenetic proteins market. They are:

• Medtronic
• Cellumed Co. Ltd.
• Sigma-Aldrich Co.
• ProSpec-Tany TechnoGene Ltd.
• Ember Therapeutics
• DePuy Synthes
• Other key market players

The report presents detailed information about the renowned manufacturers operating in the global bone morphogenetic proteins market along with the market share, key developments, revenue, and sales. It further aids in identifying the significant drivers, trends, and influential factors of the market.

rhBMP-2 Protein Sub-segment to Grow Due to Increasing Usage of Surgeons and Physicians
In terms of type, the global bone morphogenetic proteins market is categorized into rhBMP, rhBMP-7, and others. At present, the rhBMP-2 protein sub-segment is anticipated to hold the largest global bone morphogenetic proteins market share during the forecast period.

It would occur due to the increasing number of sports injuries as well as high rate of adoption and usage of rhBMP-2 protein by physicians and surgeons. Spinal fusion sub-segment, under the application segment will grow astonishingly owing to the rising number of surgeries and increasing incidence of spinal injuries.

Get PDF Brochure:
https://www.fortunebusinessinsights.com/enquiry/sample/bone-morphogenetic-proteins-market-100346

Increasing Adoption of Infuse Bone Morphogenetic Protein to Favor Growth in North America
The global bone morphogenetic proteins market is categorized into Asia Pacific, North America, the Middle East and Africa, Europe, and Latin America. Out of these regions, North America is projected to lead the global morphogenetic proteins market owing to the increasing research activities on recombinant bone morphogenetic protein and the rising adoption of infuse bone morphogenetic protein.

Furthermore, the increasing demand for bone growth stimulators will support market growth in the coming years. Europe, on the other hand, is expected to exhibit notable growth in the forthcoming years. It is likely to occur due to the rising number of orthopedic surgeries as well as the increasing incidence of spinal cord injuries. In Asia Pacific, the market will expand at a remarkable rate due to a rise in the number of awareness campaigns regarding advanced products and treatment. Besides, increasing number of standalone orthopedic clinics will fuel the market growth in this region.

Medtronic Receives FDA Approval for Clinical trial to Study Infuse Bone Graft in TLIF Spine Procedures
Medtronic, a medical device company, headquartered in Ireland, declared that it has received FDA approval for pivotal, randomized, and prospective clinical trials for the use of Infuse bone graft in September 2019.

The study will allow the usage of bone graft for Transforaminal Lumbar Interbody Fusion (TLIF) spine procedures. TLIF is a type of surgery that joins or fuses spinal bones by a posterior approach. It allows to treat few of the painful conditions of the lower back region of the spine. The company started site recruitment for the clinical trial of TLIF to register almost 50 sites with over 1,000 patients.

Speak to analyst:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/bone-morphogenetic-proteins-market-100346

Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. 
 
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. 
 
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges. 

This release was published on openPR.